跳至主要内容
临床试验/NCT01710384
NCT01710384Unknown2 期

Effect of Antenatal Corticosteroids in Late Preterm

Meir Medical Center0 个研究点目标入组 200 人开始时间: 2012年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
200
主要终点
neonate respiratory distress syndrome

研究概览

简要总结

To test the effect on premature infants of a one-time course of betamethasone administered in weeks 34-36 of gestation.

详细描述

Protocol version 3, 1/7/2012

Research Goal To test the effect on premature infants of a one-time course of betamethasone administered in weeks 34-36 of gestation.

Inclusion criteria

  1. Pregnant woman in weeks 34-36 of gestation who did not receive a betamethasone course to enhance fetal lung maturity during pregnancy

  2. Clinical, sonographic or laboratory suspicion of premature labor

  3. Singleton or twin pregnancy Exclusion criteria

  4. Premature rupture of membranes 2. Fetus with known defects 3. Suspicion of fetal distress 4. Betamethasone administered during pregnancy for any reason Research protocol Study group 100 women in weeks 34-36 of gestation with clinical, sonographic or laboratory suspicion of early labor will be recruited.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant woman in weeks 34-36 of gestation who did not receive a betamethasone course to enhance fetal lung maturity during pregnancy
  • Clinical, sonographic or laboratory suspicion of premature labor
  • Singleton or twin pregnancy

排除标准

  • Premature rupture of membranes
  • Fetus with known defects
  • Suspicion of fetal distress
  • Betamethasone administered during pregnancy for any reason

研究组 & 干预措施

betamethasoneb, 34-36 weeks, preterm labor

Experimental

betamethasone 12 mg 2 injections will be given 24-hours apart.

干预措施: betamethasone (Drug)

结局指标

主要结局

neonate respiratory distress syndrome

时间窗: 1 year

次要结局

  • 1 and 5 minute Apgar scores, and complications during the first week of life, including hypoglycemia, seizures, intubation or medications(1 week)

研究者

申办方类型
Other
责任方
Sponsor

相似试验